Newsletter
Medical Specimen Transport Container that Supports the Last Mile of “Regenerative Medicine Cell Transport” New “Vacuum-Insulated Cell Pod” Developed, Aiming for Practical Application in 2027
Miniaturizing and Individually Managing “Cell Transport” to Support the Spread of Regenerative Medicine –
Jointly Developed by Tiger Corporation and Gaudi Clinical
Tiger Corporation (CEO: Yoshisato Kikuchi, Headquarters: Kadoma City, Osaka), a global leader in thermal control technology, has jointly developed a small medical specimen transport container, the “Vacuum-Insulated Cell Pod,” with Gaudi Clinical Co., Ltd. Utilizing our stainless-steel vacuum insulation technology, this product aims to advance the cell transport process in the regenerative medicine field. We have already commenced test operations of this product in a demonstration experiment starting in April 2026.
Development Background and Demonstration Experiment Results
Conventional cell transport often relies on insulated transport boxes, which could impose operational burdens due to restricted transportation methods, difficulties when moving via public transit, and handling challenges within medical institutions. In addition, when handling multiple specimens in a single container (mixed loading), there are concerns about uncertainties and risks associated with removing or adding specific specimens. Therefore, there has been a demand to balance operational flexibility with absolute reliability to meet the highly sophisticated needs of regenerative medicine.
In this demonstration experiment, the “Vacuum-Insulated Cell Pod” was introduced into the cell transport process (collection and transport / preparation and delivery) for regenerative medicine. We verified its effectiveness in a practical operational environment regarding “temperature management,” “portability,” and “handling burden”—areas that often pose challenges in conventional transport methods. The results confirmed its potential to improve on-time delivery, reduce workload, and lower the risk of cell mix-ups.
Tiger Corporation celebrated its 100th anniversary in 2023 and has continued to evolve its founding vacuum insulation technology. This initiative expands our core strength—reliable vacuum insulation technology—into the regenerative medicine sector.
We will continue to proactively create new value in various fields where precise temperature control is demanded.
Key Features of the “Vacuum-Insulated Cell Pod”
① Reduced Transport Burden and Flexible Transportation Thanks to Lightweight design
Its compact size enables easy handling and excellent portability for individual specimens. Instead of relying on conventional transport by dedicated vehicles, it allows for flexible transportation methods, including public transit and hand-carrying. This has proven to improve on-time delivery by avoiding traffic congestion risks and streamline overall operations.
② Advancement of Temperature Control and Quality Assurance Systems
We verified the stability of temperature control, which is exceptionally critical in cell transport, under real-world operating conditions. Latent heat storage materials are used to maintain a constant temperature during transport. Despite its compact size, it successfully maintained the contents’ temperature in the 20°C range for 24 hours and the 5°C range for 11.5 hours.
A temperature logger manufactured by Pacific Industrial Co., Ltd. is built into the lid. Using the logger’s Bluetooth communication feature, it links with smartphones to acquire real-time temperature data during transport. It employs a system that triggers alerts if temperatures deviate from the specified range. All data is aggregated in the cloud, enabling centralized management at headquarters and clear visualization of temperature conditions during transport.
③ Optimizing Three Phases of Practical Operation
Collection Phase
(Medical Institutions)
[Eliminating On-site Burdens and Ensuring Safety]
- Specimens (blood, fat, etc.) collected at medical institutions are securely sealed into the Cell Pod.
- Confirmed absolute reliability and safety for storage in ultra-small spaces, as well as during the sealing and removal of specimens. Verified a reduction in staff workload through questionnaire surveys.
Preparation Phase
(Cell Processing Facilities)
[Diversifying Transport Methods and Improving Punctuality]
- Leveraging its small size and lightweight design, we introduced a delivery model utilizing hand-carrying and public transportation, rather than relying on dedicated vehicles.
- Verified the effects of avoiding traffic congestion to ensure on-time cellular manufacturing and delivery, while also saving time.
Delivery Phase
(Medical Institutions)
[Achieving Multi-Destination Delivery]
- Prepared products are delivered to medical institutions.
- Verified the feasibility of a “multi-drop” system, where a single delivery person safely carries multiple Cell Pods in a backpack to deliver to several locations simultaneously. Explored optimized delivery routes.
Stakeholder Comments
Morikuni Tobita, Representative Director and President, Gaudi Clinical Co., Ltd.
“To popularize regenerative medicine as an established medical treatment, technology that can safely transport cells while maintaining their absolute quality is indispensable. Our company is promoting the creation of a social foundation to deliver advanced medical technologies to patients safely and sustainably. The small transport container born from this joint development represents a major step forward in streamlining the delivery process, which has traditionally been a challenge. This technology, which balances portability with strict temperature control, reduces the burden on medical frontlines and enables smoother provision of treatments. Through these steady, step-by-step efforts, we aim for a future where regenerative medicine is widely trusted in local communities and becomes a standard treatment accessible to everyone.”
About Gaudi Clinical Co., Ltd.
Under the philosophy of “connecting the last mile of regenerative medicine,” the company promotes the construction of a regenerative medicine provision platform to deliver excellent technologies to patients safely and sustainably. Beyond merely providing technology, Gaudi Clinical develops “Cell Fulfillment,” a comprehensive system centered on the decentralized cell manufacturing and preparation room “KIOSK” and the treatment data management system “NEWTon.” In addition to quality control and logistics, it positions “education,” which raises literacy across the medical field, as a crucial pillar of its infrastructure. Through these initiatives, the company aims to transform regenerative medicine from a “special treatment” into a “standard, socially trusted treatment in local communities.”
About Pacific Industrial Co., Ltd.
Pacific Industrial Co., Ltd. operates diversified businesses leveraging the sensing and wireless communication technologies cultivated through its TPMS (Tire Pressure Monitoring System). The multi-sensing logger “e-WAVES,” which launched in 2021, supports logistics DX (Digital Transformation) through real-time monitoring of temperature and additional factors in the regenerative medicine, pharmaceutical, and food sectors.
* For this demonstration experiment, they provided the temperature logger system that enables advanced temperature control.
Catalog
About Industrial Equipment Solutions
Contact Us
For more information, contact us from here;
On research and development, methods of applying vacuum insulation technology,
and inquiries about partnership